Insider · CIK 0001825445

Crystal Adam

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001825445

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−600 sh	$25.32	−$15.2K	115,743
2026-10-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	233,040
2026-10-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-10-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−26.4K sh	$24.45	−$646K	116,343
2026-09-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	260,040
2026-09-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-09-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−27K sh	$22.37	−$604K	115,743
2026-08-03	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-08-03	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−5,267 sh	$26.79	−$141K	137,476
2026-08-03	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−21.7K sh	$27.35	−$594K	115,743
2026-08-03	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	287,040
2026-07-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	314,040
2026-07-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−7,371 sh	$30.25	−$223K	115,743
2026-07-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−19.6K sh	$29.34	−$576K	123,114
2026-07-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-06-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−20.9K sh	$23.06	−$481K	115,743
2026-06-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−6,140 sh	$22.25	−$137K	136,603
2026-06-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-06-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	341,040
2026-05-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	368,040
2026-05-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	142,743
2026-05-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−1,100 sh	$22.00	−$24.2K	115,743
2026-05-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−25.9K sh	$21.19	−$549K	116,843
2026-04-15	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+38.5K sh	$5.20	+$200K	151,082
2026-04-15	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−38.5K sh	—	—	395,040
2026-04-15	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−38.5K sh	$25.00	−$962K	112,622
2026-04-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−27K sh	$21.20	−$572K	112,622
2026-04-01	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+27K sh	$5.20	+$140K	139,622
2026-04-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−27K sh	—	—	433,500
2026-03-25	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	President, R&D	MExercise/Conversion	−12K sh	—	—	460,500
2026-03-25	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−12K sh	$20.11	−$241K	112,622
2026-03-25	TNGXTango Therapeutics, Inc.M Exercise/Conversion	President, R&D	MExercise/Conversion	+12K sh	$5.20	+$62.4K	124,622
2026-03-05	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−20.3K sh	$15.00	−$304K	112,622
2026-02-25	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−54.3K sh	$12.77	−$694K	132,873
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−201 sh	$12.90	−$2,592.317	187,218
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−18.3K sh	$12.26	−$224K	187,419
2026-02-02	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+285K sh	—	—	284,760
2026-02-02	TNGXTango Therapeutics, Inc.A Award	President, R&D	AAward	+47.5K sh	—	—	205,670
2025-02-05	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−6,851 sh	$3.16	−$21.7K	158,210
2025-02-04	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−7,432 sh	$2.99	−$22.2K	165,061
2025-02-03	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+318K sh	—	—	318,090
2025-02-03	TNGXTango Therapeutics, Inc.A Award	President, R&D	AAward	+53K sh	—	—	172,493
2024-02-07	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−4,083 sh	$12.62	−$51.5K	119,478
2024-02-06	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−4,288 sh	$12.56	−$53.9K	123,561
2024-02-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+280K sh	—	—	279,593
2024-02-01	TNGXTango Therapeutics, Inc.A Award	President, R&D	AAward	+46.6K sh	—	—	46,599
2023-11-01	TNGXTango Therapeutics, Inc.S Sale	President, R&D	SSale	−7,507 sh	$8.39	−$63K	81,250
2023-03-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	President, R&D	AAward	+488K sh	—	—	487,500
2023-03-01	TNGXTango Therapeutics, Inc.A Award	President, R&D	AAward	+81.3K sh	—	—	81,250
2023-01-30	CCCCC4 Therapeutics, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+3,750 sh	—	—	21,398

Recent filings

Accepted (ET)
Oct 5 17:364
Crystal Adam0001193125-26-414500
SEC(opens sec.gov)
Sep 34
Crystal Adam0001193125-26-381853
SEC(opens sec.gov)
Aug 54
Crystal Adam0001193125-26-335002
SEC(opens sec.gov)
Jul 24
Crystal Adam0001193125-26-295124
SEC(opens sec.gov)
Jun 34
Crystal Adam0001193125-26-255940
SEC(opens sec.gov)
May 54
Crystal Adam0001193125-26-207096
SEC(opens sec.gov)

Companies

Address

C/O TANGO THERAPEUTICS, INC. 201 BROOKLINE AVE., SUITE 901

BOSTON, MA, 02215